Abstrakt

Przypisy

• 1. Baumgart A.M., Molinari M.A., Silveira A.C.: Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital. Braz. J. Infect. Dis., 2010; 14: 433-436
  Google Scholar
• 2. Curran B., Jonas D., Grundmann H., Pitt T., Dowson C.G.: Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol., 2004; 42: 5644-5649
  Google Scholar
• 3. Ellington M.J., Kistler J., Livermore D.M., Woodford N.: Multiplex PCR for rapid detection of genes encoding acquired metallo-βlactamases. J. Antimicrob. Chemother., 2007; 59: 321-322
  Google Scholar
• 4. Fiett J., Baraniak A., Mrówka A., Fleischer M., Drulis-Kawa Z., Naumiuk Ł., Samet A., Hryniewicz W., Gniadkowski M.: Molecular epidemiology of acquired-metallo-β-lactamase-producing bacteria in Poland. Antimicrob. Agents Chemother., 2006; 50: 880-886
  Google Scholar
• 5. Garza-Ramos U., Tinoco P., Rojas T., Carrillo B., Barajas J.M., Suarez S., Silva-Sanchez J.: Molecular characterization of integron class 1 (In196) encoding the VIM-2 metallo-β-lactamase of Pseudomonas aeruginosa isolated from a hospital environment. J. Chemother., 2009; 21: 590-591
  Google Scholar
• 6. Lévesque C., Piché L., Larose C., Roy P.H.: PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother., 1995; 39: 185-191
  Google Scholar
• 7. List of numbered class 1 integrons. http://integrall.bio.ua.pt/ integronnumbering-lastestupdate.xls (04.10.2016)
  Google Scholar
• 8. Lister P.D., Wolter D.J., Hanson N.D.: Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev., 2009; 22: 582-610
  Google Scholar
• 9. Martis N., Leroy S., Blanc V.: Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician. J. Infect., 2014; 69: 1-12
  Google Scholar
• 10. Meletis G., Exindari M., Vavatsi N., Sofianou D., Diza E.: Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia, 2012; 16: 303-307
  Google Scholar
• 11. Moryl M.: Extracellular matrix as a microbial virulence factor in the development of human diseases. Postępy Hig. Med. Dośw., 2015; 69: 1485-1498
  Google Scholar
• 12. Nagaveni S., Rajeshwari H., Oli A.K., Patil S.A., Chandrakanth R.K.: Widespread emergence of multidrug resistant Pseudomonas aeruginosa isolated from CSF samples. Indian J. Microbiol., 2011; 51: 2-7
  Google Scholar
• 13. Papp-Wallace K.M., Endimiani A., Taracila M.A, Bonomo R.A.: Carbapenems: past, present, and future. Antimicrob. Agents Chemother., 2011; 55: 4943-4960
  Google Scholar
• 14. Patzer J., Toleman M.A., Deshpande L.M., Kamińska W., Dzierżanowska D., Bennett P.M., Jones R.N., Walsh T.R.: Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother., 2004; 53: 451-456
  Google Scholar
• 15. Pseudomonas aeruginosa MLST Database. http://pubmlst.org/ paeruginosa (04.01.2017)
  Google Scholar
• 16. Sacha P., Zórawski M., Hauschild T., Wieczorek P., Jaworowska J., Jakoniuk P., Tryniszewska E.: The presence of blaIMP genes on plasmids DNA isolated from multidrug-resistant Pseudomonas aeruginosa strains at University Hospital in Bialystok (Poland) – first report. Folia Histochem. Cytobiol., 2007; 45: 405-408
  Google Scholar
• 17. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B.: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 1995; 33: 2233-2239
  Google Scholar
• 18. Teo J.W., La M.V., Jureen R., Lin R.T.: Emergence of a New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa in Singapore. Emerg. Microbes Infect., 2015; 4: e72
  Google Scholar
• 19. The European Committee on Antimicrobial Susceptibility Testing – EUCAST. http://www.eucast.org/clinical_breakpoints/ (09.08.2016)
  Google Scholar
• 20. Tsuchimochi N., Takuma T., Shimono N., Nagasaki Y., Uchida Y., Harada M.: Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa. J. Infect. Chemother., 2008; 14: 99-104
  Google Scholar
• 21. Walsh T.R., Toleman M.A., Hryniewicz W., Bennett P.M., Jones R.N.: Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother., 2003; 52: 116-119
  Google Scholar
• 22. Willmann M., Kuebart I., Marschal M., Schröppel K., Vogel W., Flesch I., Markert U., Autenrieth I.B., Hölzl F., Peter S.: Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study. BMC Infect. Dis., 2013; 13: 515
  Google Scholar

Pełna treść artykułu